Parkwalk have launched our annual ‘Equity Investments into Spinouts’ 2024 report, in conjunction with Beauhurst.
The report reveals that UK spinout investment is showing signs of recovery following a challenging year in 2023.
- UK spinout investment is expected to reach £2.3bn in 2024
- Life Sciences sector is thriving with 210 deals for UK spinouts between H2 2023 and H1 2024
- Parkwalk remains the UK’s leading investor in university spinouts backing 29 businesses in 2023